GO
Loading...

Shire says ready to recommend higher AbbVie offer

Shire said on Monday it was ready to recommend a newly revised higher offer from AbbVie, valuing the London-listed drugmaker at £53.20 pounds ($90.53) per share.

AbbVie, which wants to buy Shire to cut its tax bill and diversify its product line-up, raised its cash-and-stock offer for Shire to £51.15 a share last Tuesday.

Read MoreUK to demand job assurances in foreign takeovers

On Monday the firm said it had requested and received a higher proposal comprising £24.44 in cash and 0.8960 shares of new AbbVie per Shire share.

Under the offer, Shire shareholders would own approximately 25 percent of the combined new firm.

Follow us on Twitter: @CNBCWorld

Contact Europe News

  • CNBC NEWSLETTERS

    Get the best of CNBC in your inbox

    Please choose a subscription

    Please enter a valid email address
    To learn more about how we use your information,
    please read our Privacy Policy.

Europe Video

  • IMF discusses role in Egypt

    Masood Ahmed, director of Middle East and Central Asia at the IMF, says that the IMF has two roles to play with Egypt, one of which is to provide dialogue and the other is to provide financial support.

  • IMF: Egypt has 'a long way to go'

    Masood Ahmed, director of Middle East and Central Asia at the IMF, says that Egypt has made a lot of improvements regarding energy subsidies and broader reforms, but still has "a long way to go."

  • Is Greece spiralling out of control?

    Peter Rosenstreich, chief FX analyst at Swissquote Bank, says the negotiations between creditors and Greece may not end well.